Institute of Biochemistry of Biologically Active Compounds

https://ibiochemistry.by/  

Liver (iecur) protectant for alcoholic steatohepatitis

COUNTRY OF ORIGIN

Belarus

IDENTIFIER

BO4843

PUBLISHED

2022-03-03

LAST UPDATE

2022-03-06

DEADLINE

Linked profile in other language
Responsible
Summary
The Institute of Biochemistry of Bioactive Compounds offers consumers a liver protection agent for alcoholic steatohepatitis under a manufacturing agreement, provides application services under on an outsourcing agreement, and is looking for partners interested in a distribution service agreement.
Description
The mechanism of the protective effect of borage oil is due to its antioxidant effect and is realized through the normalization of the content of cytochrome P-450 and the activity of cytochrome P-450-dependent enzymes due to the ordering of the lipid environment of cytochrome.
Advantages and Innovations
A preparation of borage seed oil can be used as a dietary supplement in patients with alcoholic steatohepatitis.
Stage of development
Field tested/evaluated (TRL8)
Funding source
State budged
Internal
IPR status
Exclusive rights
Secret know-how
Sector group
Agrofood
BioChemTech
Healthcare

Client information

Type
R&D institution
Year established
1970
NACE keywords
Q.86.90 - Other human health activities
M.72.11 - Research and experimental development on biotechnology
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Turnover (in EUR)
1-10M
Already engaged in transnational cooperation
Yes
Additional comments
In the structural subdivisions of the institute, research is carried out in the field of vitaminology, the study of molecular mechanisms of regulation of metabolism in normal and pathological conditions, the biochemistry of alcohol and drug addiction, neurochemistry and pharmacology.

The main activities are as follows: conducting fundamental and applied research aimed at studying the mechanisms of pathogenesis of diseases of the liver, cardiovascular and endocrine systems, alcohol dependence, pathological conditions associated with a deficiency of essential micronutrients and the effects of stress, in order to develop methods for their prevention, diagnosis and therapy; development of new innovative medicines, vitamin preparations, dietary supplements, as well as the development of methods for the isolation and purification of biologically active compounds from herbal medicinal raw materials, the development of their laboratory production for the needs of the pharmaceutical industry.

The Institute has developed unique technologies for obtaining dry extracts from medicinal plant materials and spicy-aromatic plants for use as components:
- in the production of dietary supplements,
- in the food industry,
- in the production of perfumery.

Production under the order of products of deep processing and purification of extracts from vegetable raw materials for use as analytical standards is possible.
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Outsourcing agreement
Type and role of partner sought
Consumers interested in purchasing a liver protectant for alcoholic steatohepatitis under a manufacturing agreement.

Consumers interested in alcoholic steatohepatitis liver protectant services under an outsourcing agreement.

Distributors interested in purchasing alcoholic steatohepatitis liver protector under a distribution services agreement.
Type and size of partner sought
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution
University

Attachments

Views: 669
Statistics since 03.03.2022 16:45:47